Cargando…

Targeting Epigenetic Mechanisms in Vascular Aging

Environment, diseases, lack of exercise, and aged tendency of population have becoming crucial factors that induce vascular aging. Vascular aging is unmodifiable risk factor for diseases like diabetes, hypertension, atherosclerosis, and hyperlipidemia. Effective interventions to combat this vascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Zhongxiao, Ding, Qian, Li, Xinzhi, Feng, Yuliang, He, Hao, Huang, Chuoji, Zhu, YiZhun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764463/
https://www.ncbi.nlm.nih.gov/pubmed/35059451
http://dx.doi.org/10.3389/fcvm.2021.806988
_version_ 1784634171782594560
author Lin, Zhongxiao
Ding, Qian
Li, Xinzhi
Feng, Yuliang
He, Hao
Huang, Chuoji
Zhu, YiZhun
author_facet Lin, Zhongxiao
Ding, Qian
Li, Xinzhi
Feng, Yuliang
He, Hao
Huang, Chuoji
Zhu, YiZhun
author_sort Lin, Zhongxiao
collection PubMed
description Environment, diseases, lack of exercise, and aged tendency of population have becoming crucial factors that induce vascular aging. Vascular aging is unmodifiable risk factor for diseases like diabetes, hypertension, atherosclerosis, and hyperlipidemia. Effective interventions to combat this vascular function decline is becoming increasingly urgent as the rising hospitalization rate caused by vascular aging-related diseases. Fortunately, recent transformative omics approaches have enabled us to examine vascular aging mechanisms at unprecedented levels and precision, which make our understanding of slowing down or reversing vascular aging become possible. Epigenetic viz. DNA methylation, histone modifications, and non-coding RNA-based mechanisms, is a hallmark of vascular aging, its deregulation leads to aberrant transcription changes in tissues. Epigenetics mechanisms by mediating covalent modifications to DNA and histone proteins, consequently, influence the sensitivity and activities of signaling pathways in cells and tissues. A growing body of evidence supports correlations between epigenetic changes and vascular aging. In this article, we will provide a comprehensive overview of epigenetic changes associated with vascular aging based on the recent findings with a focus on molecular mechanisms of action, strategies to reverse epigenetic changes, and future perspectives.
format Online
Article
Text
id pubmed-8764463
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87644632022-01-19 Targeting Epigenetic Mechanisms in Vascular Aging Lin, Zhongxiao Ding, Qian Li, Xinzhi Feng, Yuliang He, Hao Huang, Chuoji Zhu, YiZhun Front Cardiovasc Med Cardiovascular Medicine Environment, diseases, lack of exercise, and aged tendency of population have becoming crucial factors that induce vascular aging. Vascular aging is unmodifiable risk factor for diseases like diabetes, hypertension, atherosclerosis, and hyperlipidemia. Effective interventions to combat this vascular function decline is becoming increasingly urgent as the rising hospitalization rate caused by vascular aging-related diseases. Fortunately, recent transformative omics approaches have enabled us to examine vascular aging mechanisms at unprecedented levels and precision, which make our understanding of slowing down or reversing vascular aging become possible. Epigenetic viz. DNA methylation, histone modifications, and non-coding RNA-based mechanisms, is a hallmark of vascular aging, its deregulation leads to aberrant transcription changes in tissues. Epigenetics mechanisms by mediating covalent modifications to DNA and histone proteins, consequently, influence the sensitivity and activities of signaling pathways in cells and tissues. A growing body of evidence supports correlations between epigenetic changes and vascular aging. In this article, we will provide a comprehensive overview of epigenetic changes associated with vascular aging based on the recent findings with a focus on molecular mechanisms of action, strategies to reverse epigenetic changes, and future perspectives. Frontiers Media S.A. 2022-01-04 /pmc/articles/PMC8764463/ /pubmed/35059451 http://dx.doi.org/10.3389/fcvm.2021.806988 Text en Copyright © 2022 Lin, Ding, Li, Feng, He, Huang and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Lin, Zhongxiao
Ding, Qian
Li, Xinzhi
Feng, Yuliang
He, Hao
Huang, Chuoji
Zhu, YiZhun
Targeting Epigenetic Mechanisms in Vascular Aging
title Targeting Epigenetic Mechanisms in Vascular Aging
title_full Targeting Epigenetic Mechanisms in Vascular Aging
title_fullStr Targeting Epigenetic Mechanisms in Vascular Aging
title_full_unstemmed Targeting Epigenetic Mechanisms in Vascular Aging
title_short Targeting Epigenetic Mechanisms in Vascular Aging
title_sort targeting epigenetic mechanisms in vascular aging
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764463/
https://www.ncbi.nlm.nih.gov/pubmed/35059451
http://dx.doi.org/10.3389/fcvm.2021.806988
work_keys_str_mv AT linzhongxiao targetingepigeneticmechanismsinvascularaging
AT dingqian targetingepigeneticmechanismsinvascularaging
AT lixinzhi targetingepigeneticmechanismsinvascularaging
AT fengyuliang targetingepigeneticmechanismsinvascularaging
AT hehao targetingepigeneticmechanismsinvascularaging
AT huangchuoji targetingepigeneticmechanismsinvascularaging
AT zhuyizhun targetingepigeneticmechanismsinvascularaging